The study’s limitations also include potential selection or referral bias associated with analyzing data from a single specialized institution, and the likely exclusion of some patients with Lynch syndrome who have unknown MLH1 methylation status, as some sporadic cases of Lynch syndrome may be due to silencing by the hypermethylation of the MLH1 promoter. The gene discussed is MLH1; the disease is Lynch syndrome.